Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
05/2002
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents
05/09/2002US20020055181 Light generating compound for use in the detection of preferential particles in sample
05/09/2002US20020053288 Method for collecting reversely subliming substance and apparatus therefor
05/08/2002EP1203770A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases
05/08/2002EP1202729A1 Phosphate transport inhibitors
05/08/2002DE10054932A1 Antiviral medicaments containing new or known chroman-4-one or chroman-4-one derivatives, especially effective against hepatitis B virus infections
05/08/2002CN1348447A 4,5-diaryl-3(i(2H))-furanone derivatives as cyclooxygenase-2 inhibitors
05/08/2002CN1084333C Novel artemisine compounds their producing process and pharmaceutical composition containing them
05/07/2002US6384230 2,6-dimethyl-5-((4-ethoxyphenyl)-methoxy)-7-(2-methylthiazol-4-yl)hepta -2,6-dienoic acid ethyl ester from malic acid, wittig reaction with 2-methyl-4-thiazolylmethyl triphenyl phosphonium bromide; intermediates for epothilone a or b
05/07/2002US6384045 Tricyclic and tetracyclic pyrones
05/02/2002WO2002034745A1 Chemokine receptor binding heterocyclic compounds
05/02/2002WO2002034736A1 Process for preparation of bicyclic and polycyclic molecules
05/02/2002WO2002011677A3 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/02/2002US20020052516 Process for the production of anhydrosugar alcohols
05/02/2002US20020052499 Photochromic naphthopyrans
05/02/2002US20020052400 Substituted O- and/or S heterocyclic compounds; powerful ligands for melatoninergic receptors.
05/02/2002US20020052384 Furopyrimidines and pyrrolopyrimidines; treating cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients.
05/02/2002EP1201666A2 Epothilones with a modified side chain
05/02/2002EP1200444A1 Novel xanthone compounds, their preparation and use as medicament
05/02/2002EP0765336B1 Synthesis of conduritol epoxides and aziridines and methods of using such to synthesize higher disaccharides
05/02/2002CA2427021A1 Process for preparation of bicyclic and polycyclic molecules
05/02/2002CA2421796A1 Chemokine receptor binding heterocyclic compounds
05/01/2002CN1346851A Polycyclic dyes
04/2002
04/30/2002US6380395 Anticancer agents
04/30/2002US6380394 Anticancer agents
04/30/2002US6380258 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
04/30/2002US6380257 Used as glucose-6-phosphate translocase inhibitors and can be used in therapy of diabetes mellitus
04/30/2002US6380246 For combating pests and weeds
04/30/2002US6380227 Fermentative preparation process for and crystal forms of cytostatics
04/30/2002US6380196 Bronchial therapeutics, bronchial dilators
04/30/2002CA2062496C Avermectin compounds with a 6,5-spiroketal ring system
04/30/2002CA2059787C Hydrazine derivative and pesticidal composition comprising said derivative as an effective ingredient
04/25/2002WO2002032905A1 Medicinal compositions, dose and method for treating malaria
04/25/2002WO2002032891A1 Flavan compounds, their preparation and their use in therapy
04/25/2002WO2002032844A2 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
04/25/2002WO2001092266A3 Process for the manufacture of anhydro sugar alcohols
04/25/2002WO2001081341A3 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
04/25/2002US20020049341 Photochromic spiropyrans, and compositions and articles containing same
04/25/2002US20020049251 Wedelolactone and its synthesis for treating neurodegenerative diseases
04/25/2002US20020049221 Analogs of deoxypreussomerin, palmarumycin CPI and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system
04/25/2002US20020049201 Sulfonamide inhibitors of aspartyl protease
04/24/2002EP1035858B1 Use of ginkgo biloba extracts for preparing a medicine
04/23/2002US6376539 Antiischemic agents, central nervous system disorders
04/23/2002CA2198198C Polymerizable hybrid monomers
04/18/2002WO2002030937A2 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
04/18/2002WO2002030929A1 Novel pleuromutilin derivatives
04/18/2002WO2002030908A1 Inhibitors of protein kinases
04/18/2002WO2002030438A1 Anticancer composition comprising sesquiterpenes isolated from resina ferulae
04/18/2002WO2002030356A2 Synthesis of epothilones and relates analogs
04/18/2002US20020045764 Tubulin binding compounds (COBRA)
04/18/2002US20020045750 Asymetric hemisynthesis of harringtonines and their analogs, that are alkaloids used in chemotherapy.
04/18/2002US20020045609 Epothilone derivatives and methods for making and using the same
04/18/2002US20020045228 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
04/18/2002US20020044885 Device and method for photoactivation
04/18/2002DE10051136A1 New alpha-hydroxy-ketone derivatives, useful as intermediates for biologically active polyketides, terpenoids, epothilones and their derivatives
04/18/2002CA2425828A1 Synthesis of epothilones and related analogs
04/18/2002CA2394084A1 Inhibitors of protein kinases
04/17/2002EP1196956A2 Oligomeric and polymeric oled materials produced via arylation of quinones
04/17/2002EP1196388A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
04/17/2002EP1196164A2 Methods and compositions for regulating gut motility and food intake
04/17/2002EP1005464B1 Photochromic naphthopyrans
04/17/2002EP0749305B1 Process for making avermectin/zein compositions
04/17/2002CN1344714A Prep. of pyrone compound
04/17/2002CN1082962C 1,7-diaroxy-or 1,7-diarylthio-substituted perylene-3,4,9,10-tetracarboxylic acid and their dianhydrides and diimides, prep. and use thereof
04/16/2002US6372781 Compounds for treating gastroduodenal diseases
04/16/2002CA2260413C Terpenoid lactone compounds and their production process
04/11/2002WO2002028866A2 Hydroxyesters of 7-desmethylrapamycin
04/11/2002WO2002028862A2 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
04/11/2002US20020042525 Process for producing pyrone compounds
04/11/2002US20020042085 Produce light energy when decomposed; stable at room temperature
04/11/2002CA2424555A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders
04/11/2002CA2423888A1 Hydroxyesters of 7-desmethylrapamycin
04/10/2002EP1195412A1 Polycyclic dyes
04/10/2002EP1194404A1 Inhibitors of aspartyl protease
04/10/2002EP1109802B1 Spirofluorenopyrans
04/09/2002US6369243 Acid catalyst
04/09/2002US6369241 Multistage reaction of ketoester with 1,3,5-trihydroxybenzene to produce dihydroxyoxocoumarone, coupling and cyclization
04/09/2002US6369234 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
04/09/2002US6369102 Glaucoma
04/09/2002US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
04/09/2002US6368520 Synergistic stabilizer mixture
04/04/2002WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents
04/04/2002WO2001092246A3 Continuous process for the manufacture of anhydro sugar alcohols
04/04/2002WO2001039720A3 Dna polymerase inhibitors, mikanolide and dihydromikanolide
04/04/2002CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents
04/03/2002EP1193263A1 Process for producing pyrone compounds
04/03/2002EP1192162A2 Taxane derivatives and processes for the preparation thereof
04/03/2002EP1053472A4 Energy transfer dyes
04/02/2002US6365759 Intermediate compounds for preparing macrocylcic analogs
04/02/2002US6365610 1,4-epoxy-2,3-benzodioxepins or 1,4-epoxy-3,2-benzoxazepines
04/02/2002US6364465 Ink jet heads having photoresist layer containing poly (amic acid)
03/2002
03/28/2002US20020038048 Catalytic asymmetric desymmetrization of meso compounds
03/28/2002US20020037428 Oligomeric and polymeric OLED materials produced via-arylation of quinones
03/27/2002EP1191020A2 Material for organic electroluminescence device and use thereof
03/27/2002CN1342156A Inhibition and treatment of hepatitis B virus and flavivirus by helioxanthin and its analogs
03/27/2002CN1341597A Novel anti-tumor active matter bacillosporin P
03/26/2002US6362222 Topical applying
03/26/2002US6362220 Administering a sulfamic acid compound
03/26/2002US6362168 Antiparasitic agents